JPMorgan Reiterates Overweight Rating on Biohaven Pharmaceutical Holding (BHVN)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| (NYSE: BHVN) | Delayed: 15.42 -1.07 (6.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.49 | 52 Week High | $ | |||
| Open | $15.46 | 52 Week Low | $ | |||
| Day High | $16.33 | P/E | N/A | |||
| Day Low | $15.12 | EPS | $ | |||
| Volume | 3,164,693 | |||||
